Issuer Information

EDGAR: Contact Information
  • Name:
    Verrica Pharmaceuticals Inc.
  • Address:
    44 W. Gay St., Suite 400
    WEST CHESTER, PENNSYLVANIA 19380
  • Phone:
    484-453-3300
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
577620: 0001231919-25-000594
First Sale: 2025-11-25
Security Type(s): Equity
Offer Amount: $50,017,383
Amount Sold: $50,017,383
06b

CA, GA, NY, OR, PA, TX, VA,

257846: 0001660334-18-000002
First Sale: 2018-02-20
Security Type(s): Equity
Offer Amount: $21,000,000
Amount Sold: $19,999,995
Remaining: $1,000,005
06b

CA, MD, OH, VA,

253236: 0001660334-17-000003
First Sale: 2017-12-15
Security Type(s): Equity
Offer Amount: $5,000,000
Amount Sold: $5,000,000
06b No Notices in EFD for this offering.
154933: 0001140361-15-044797
First Sale: 2015-12-02
Security Type(s): Equity
Amount Sold: $2,434,186
06b No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.